Typically, when one hears that a player is heading to Dr. James Andrews for a second opinion, that player is going to miss quite a bit of time. In this case, the Boston Red Sox and David Price received better news than they could have hoped.
When the Boston Red Sox announced that David Price was dealing with elbow pain, it was a bad sign. When it was further stated that he was set to seek a second opinion from Dr. James Andrews, the worst was expected. After all, no one goes to see the good doctor to hear that their elbow is in pristine shape. Naturally, it was expected that Price would, at the very least, miss a decent chunk of time.
However, Price and the Red Sox actually received good news from Dr. Andrews. Instead of undergoing the knife, Price has been advised to rest for seven to ten days. From that point, treatment will be determined. He is not even going to require an injection at this time.
Article continues below ...
No surgery for Price. No PRP. Farrell calls it best case scenario. Down for next 7-10 days
If this is not the best case scenario for the Red Sox and Price, it is really close. Instead of possibly losing their presumptive second starter for the year, he may be able to get back on a mound within a few weeks. However, depending on how long the treatment lasts, he may still need to spend time on the disabled list at the start of the season.
Nonetheless, it is an inauspicious start for Price’s second season in Boston. While he did post a 17-9 record and lead the American League in innings in 2016, he never quite seemed comfortable with the Red Sox. He also flamed out in the postseason yet again, leading the fanbase to further question that seven year, $217 Million contract he received.
Price also knows that the pressure is on this year. He has alluded to his postseason struggles on Twitter several times this offseason, promising the fans that he will improve. An extended stay on the disabled list would have just furthered those seeds of doubt, perhaps even from Price himself. Although he will still be sidelined, Price should be able to remain a key part of the Red Sox plans for 2017.